Tricyclic inhibitors of 5-lipoxygenase

Details Tricyclic inhibitors of 5-lipoxygenase Tricyclic inhibitors of 5-lipoxygenase

2011-04-05

2011-04-05

Desai, Rita J (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S290000

Reexamination Certificate

active

07919621

ABSTRACT:
Described herein are compounds and pharmaceutical compositions containing such compounds, which inhibit the activity of 5-lipoxygenase (5-LO). Also described herein are methods of using such 5-LO inhibitors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions, diseases, or disorders.

REFERENCES:
patent: 4134974 (1979-01-01), Melloni et al.
patent: 4774245 (1988-09-01), Watjen et al.
patent: 4999354 (1991-03-01), Hansen et al.
patent: 5166343 (1992-11-01), Wade
patent: 5424320 (1995-06-01), Fortin et al.
patent: 5426111 (1995-06-01), Dellaria et al.
patent: 5552437 (1996-09-01), Delorme et al.
patent: 5610158 (1997-03-01), Bisaha et al.
patent: 5922707 (1999-07-01), Thomas et al.
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Bird, T.G. et al., “(Methoxyalkyl)thiazoles: A New Series of Potent, Selective, and Orally Active 5-Lipoxygenase Inhibitors Displaying High Enantioselectivity,” J. Med. Chem. 34:2176-2186 (1991).
Elisa et al., “Fused pyrimidines. Synthesis of new derivatives of potential diureticactivity,” Boll, Chim. Farm. 135:585 (1996).
Brink, C. et al., “International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors,” Pharmacol. Rev. 55:195-227 (2003).
Brooks, C.D. et al., “Design of inhibitors of leukotriene biosynthesis and their therapeutic potential,” Pure & Applied Chem. 70(2):271-274 (1998).
Brooks, C.D. and Summers, J.B., “Modulators of Leukotriene Biosynthesis and Receptor Activation,” J. Med. Chem. 39(14):2629-2654 (1996).
Busse, W.W., “The role of leukotrines in asthma and allergy rhinitis,” Clin. Exp. Allergy 26:868-879 (1996).
Crawley, G.C. et al., “Methoxytetrahydropyrans. A New Series of Selective and Orally Potent 5-Lipoxygenase Inhibitors,” J. Med. Chem. 35:2600-2609 (1992).
Folco, G. et al., “Leukotrienes in Cardiovascular Diseases,” Am. J. Respir. Crit. Care Med. 161(2 Pt.2):S112-S116 (2000).
Ford-Hutchinson et al., A.W., “5-Lipoxygenase,” Annu. Rev. Biochem. 63:383-417 (1994).
Homaidan, F.R. et al, “Protein Regulators of Eicosanoid Synthesis: Role in Inflammation,” Current Protein and Peptide Science 3:467-484 (2002).
Jala et al., “Leukotrienes and atherosclerosis: new roles for old mediators,” Trends in Immunol. 25:315-322 (2004).
Lambert-van der Brempt, C. et al., “Conformational Analysis of 5-Lipoxygenase Inhibitors: Role of the Substituents in Chiral Recognition and on the Active Conformations of the (Methoxyalkyl)thiazole and Methoxytetrahydropan Series,” J. Med. Chem. 37:113-124 (1994).
Leff, A.R. et al., “Discovery of leukotrienes and development of antileukotriene agents,”Ann. Allergy Asthma Immunol. 86 (Supp1.1):4-8 (2001).
Lotzer, K. et al., “The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis,” Biochim. Biophys. Acta 1736:30-37 (2005).
Mano et al., “Optimization of Imidazole-5-Lipoxygenase Inhibitors and Selection and Synthesis of a Development Candidate,” Chem. Pharm. Bull. 53:965-973 (2005).
Marone, G. et al., “Cardiovascular and Metabolic Effects of Peptide Leukotrines in Man,”Biology of Leukotrienes, eds. R. Levi and R.D. Krell, Ann. New York Acad. Sci. 524:321-333 (1988).
McQuaid, L.A. et al., “Synthesis and Excitatory Amino Acid Pharmacology of a Series of Heterocyclic-Fused Quinoxalinones and Quinazolinones,” J. Med. Chem. 35(18):3319 -3324 (1992) >.
Musser, J.H. and Kreft, A.F., “5-Lipoxygenase: Properties, Pharmacology, and the Quinolinyl(bridged)aryl Class of Inhibitors,” J. Med. Chem. 35:2501-2524 (1992).
O'Byrne, P.M., “Leukotrines in the Pathogenesis of Asthma,” Chest 111 (Supp.2):27S-34S (1997).
Riccioni, G. et al, “Brief Review. Advances in Therapy with Antileukotriene Drugs,” Ann. Clin. Lab Sci. 34(4):379-387 (2004).
Steinhilber, D., “5-Lipoxygenase: A Target for Antiinflammatory Drugs Revisited,” Curr. Med. Chem. 6(1):71-85 (1999).
Werz, “Pharmacological intervention with 5-lipoxygenase: new insights and novel compounds,” Exp. Op. Ther. Patents 15:505-519 (2005).
Young, R.N., “Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?” Eur. J. Med. Chem 34:671-685 (1999).
PCT/US07/01618 Search Report dated Nov. 26, 2007.

Affiliated with

Also associated with

Rating

Tricyclic inhibitors of 5-lipoxygenase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tricyclic inhibitors of 5-lipoxygenase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic inhibitors of 5-lipoxygenase will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2655675